主要收入构成
报告期：2022-12-31
| 主营产品构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 冲剂 |
6.35% |
93.33 |
-5.16% |
92.86 |
0.50% |
32.29% |
| 粉针剂 |
10.87% |
159.68 |
17.14% |
89.71 |
43.82% |
-17.76% |
| 胶剂 |
3.37% |
49.53 |
-18.03% |
43.57 |
12.05% |
-15.26% |
| 胶囊剂 |
3.88% |
56.93 |
-4.69% |
41.76 |
26.66% |
-12.96% |
| 口服液 |
4.66% |
68.49 |
21.53% |
82.08 |
-19.83% |
24.31% |
| 片剂 |
13.42% |
197.09 |
16.10% |
68.44 |
65.27% |
0.36% |
| 其他（补充） |
1.48% |
21.80 |
29.21% |
16.31 |
25.21% |
-16.62% |
| 其他产品 |
0.59% |
8.70 |
78.14% |
6.28 |
27.85% |
7.64% |
| 水针剂 |
45.00% |
660.91 |
55.80% |
167.38 |
74.67% |
-5.81% |
| 药品药械经销 |
0.03% |
0.37 |
-99.84% |
0.34 |
9.90% |
-14.09% |
| 原料药 |
10.34% |
151.82 |
-39.38% |
121.33 |
20.08% |
3.01% |
| 总计 |
1468.67 |
| 行业收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 其他（补充） |
1.48% |
21.80 |
29.21% |
16.31 |
25.21% |
-16.62% |
| 医药工业 |
88.28% |
1296.50 |
5.12% |
586.48 |
54.76% |
10.46% |
| 医药商业 |
10.24% |
150.37 |
-42.66% |
127.26 |
15.36% |
-12.58% |
| 总计 |
1468.67 |
| 地区收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 东北地区 |
8.57% |
125.80 |
12.78% |
50.69 |
59.70% |
10.57% |
| 华北地区 |
10.06% |
147.75 |
8.74% |
60.21 |
59.25% |
-2.19% |
| 华东地区 |
24.45% |
359.03 |
18.88% |
143.70 |
59.98% |
23.15% |
| 华南地区 |
8.91% |
130.79 |
-25.95% |
69.31 |
47.01% |
14.92% |
| 华中地区 |
36.99% |
543.23 |
-8.10% |
307.84 |
43.33% |
3.13% |
| 其他（补充） |
1.48% |
21.80 |
29.21% |
16.31 |
25.21% |
-16.62% |
| 西北地区 |
2.90% |
42.57 |
-22.00% |
15.79 |
62.91% |
-1.51% |
| 西南地 |
6.65% |
97.70 |
-- |
66.21 |
32.23% |
-- |
| 总计 |
1468.67 |
